MSD | Home Skip to content Search everything Close Menu Close Main menu Company Who we are What we do Stories History Sustainability Sustainability overview Philanthropy MSD Medical Outreach Program Impact Venture Fund Transparency disclosures Sustainability resources Leadership Leadership overview Board of directors Executive team Culture & values Culture & values overview Code of conduct, ethics and compliance Diversity and inclusion Policies and positions Suppliers Suppliers overview Supplier registration Supplier help for Ariba Research Research overview Areas of focus Oncology Vaccines Infectious diseases Cardiometabolic and respiratory diseases Immunology Neuroscience Ophthalmology Areas of innovation Data science and artificial intelligence Green and sustainable science Our therapeutic modalities Translational medicine Pipeline Business development and licensing Clinical Trials Clinical trials overview Diversity in clinical trials R&D locations How we invent Meet our scientists Publications Safety data sheets (SDS) Product patents Patients Patients overview Play an active role in your health care Fighting counterfeit medicine Media Media overview News releases Company statements Company fact sheet Investors Investors overview Events and presentations Stock information Careers Who we are Learn more Contact us What can we help you find? Search for: Making an impact in cardiometabolic and respiratory diseases We’re committed to advancing research to help more patients living with diseases that impact the heart and lungs Learn more about our work Research The journey to invention and discovery is guided by science — and inspired by patients. Investors Find our latest financials, events & presentations, news, stock information and contacts. Sustainability We operate responsibly every day to enable a safe and healthy future for people and communities globally. Explore our stories Innovation Macrocyclic peptides: a new research frontier Health awareness Understanding the health risks of high LDL cholesterol Health awareness VIDEO: Living with pulmonary arterial hypertension Health awareness Staying positive with pulmonary arterial hypertension 1 Read more stories About us For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. Who we are What we do × Pipeline We follow the science where we can make the greatest difference, now and in the future. Pipeline × Clinical trials Clinical trials help find new treatments to help save and improve lives. Our progress is due in large part to the important and tough scientific questions we set out to answer with our trials and collaborations. Learn more about clinical trials × Connect with us on social For patients and health care professionals MSD Manuals Medical information source covering thousands of topics in all fields of medicine Clinical trials Learn about our clinical trials and find available studies Sustainability Impact Report Reporting on our commitment to operating responsibly to benefit society MSD for Mothers An initiative to create a world where no woman has to die giving life About MSD MSD Animal Health The global animal health business unit of MSD Contact Us If you have a question or need more information about us, find out who you should contact. Forward-looking statementCookie policyCookie PreferencesPrivacyTerms of useAccessibilitySitemap Copyright © 2026 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved. This website of Merck & Co., Inc., Rahway, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline candidates that the candidates will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s Annual Report on Form 10-K for the year ended December 31, 2025 and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (***********). No Duty to Update The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date. Decline Accept
